Header Logo
Last Name
KP Region

Duc Ha, MD, MAS

TitleClinician Investigator
InstitutionKaiser Permanente Colorado
DepartmentInstitute for Health Research
ORCID ORCID IconLogin to create your ORCID iD Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Ha is an early-stage Clinician Investigator at the Kaiser Permanente Colorado Institute for Health Research. His research interests include physical activity and exercise, lung cancer survivorship, and lung cancer outcomes. He is particularly interested in the role of physical activity and exercise in improving the health status of lung cancer survivors following curative-intent therapy.

    Dr. Ha received his medical training at the University of Colorado Denver School of Medicine, completed residency in Internal Medicine at the Cleveland Clinic, and Pulmonary/Critical Medicine and Postdoctoral Research fellowships at the University of California San Diego. While in fellowship, he also obtained a Master of Advanced Study (MAS) degree in clinical research.

    Dr. Ha is a long-standing member of the American Thoracic Society and more recently, the American Society of Clinical Oncology.

    Collapse Research 
    Collapse research activities and funding
         May 1, 2019 - Dec 31, 2019
    Exercise in Lung Cancer
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Ha D, Ries AL, Montgrain P, Vaida F, Sheinkman S, Fuster MM. Time to treatment and survival in veterans with lung cancer eligible for curative intent therapy. Respir Med. 2018 08; 141:172-179. PMID: 30053964.
      View in: PubMed
    2. Ha D, Ries AL, Mazzone PJ, Lippman SM, Fuster MM. Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancer. Support Care Cancer. 2018 Jul; 26(7):2459-2469. PMID: 29429006.
      View in: PubMed
    3. Ha D, Liao X, Wang HY, Jamieson C, Magaña M, Makani S. Thoracic Extramedullary Hematopoiesis Mimicking Metastatic Cancer. J Bronchology Interv Pulmonol. 2016 Oct; 23(4):343-346. PMID: 27479013.
      View in: PubMed
    4. Ha D, Mazzone PJ, Ries AL, Malhotra A, Fuster M. The Utility of Exercise Testing in Patients with Lung Cancer. J Thorac Oncol. 2016 09; 11(9):1397-410. PMID: 27156441.
      View in: PubMed
    5. Ha D, Fuster M, Ries AL, Wagner PD, Mazzone PJ. Heart Rate Recovery as a Preoperative Test of Perioperative Complication Risk. Ann Thorac Surg. 2015 Nov; 100(5):1954-62. PMID: 26410158.
      View in: PubMed
    6. Ha D, Yadav R, Mazzone PJ. Cystic lung disease: systematic, stepwise diagnosis. Cleve Clin J Med. 2015 Feb; 82(2):115-27. PMID: 25897602.
      View in: PubMed
    7. Ha D, Choi H, Chevalier C, Zell K, Wang XF, Mazzone PJ. Survival in patients with metachronous second primary lung cancer. Ann Am Thorac Soc. 2015 Jan; 12(1):79-84. PMID: 25494009.
      View in: PubMed
    8. Ha D, Choi H, Zell K, Raymond DP, Stephans K, Wang XF, Videtic G, McCarthy K, Minai OA, Mazzone PJ. Association of impaired heart rate recovery with cardiopulmonary complications after lung cancer resection surgery. J Thorac Cardiovasc Surg. 2015 Apr; 149(4):1168-73.e3. PMID: 25583106.
      View in: PubMed
    9. Ha D, Choi H, Almeida FA, Arrossi A, Brainard J, Cicenia J, Farver C, Gildea T, Machuzak MS, Mazzone P. Histologic and molecular characterization of lung cancer with tissue obtained by electromagnetic navigation bronchoscopy. J Bronchology Interv Pulmonol. 2013 Jan; 20(1):10-5. PMID: 23328135.
      View in: PubMed
    Ha's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Similar People Expand Description
    Same Department Expand Description

    © 2020 Kaiser Permanente

    KP Researcher Profiles is funded by Kaiser Permanente Research.